Literature DB >> 20806364

Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia.

Emilie Macher1, François Dubos, Nathalie Garnier, Mathilde Delebarre, Eva De Berranger, Estelle Thebaud, Françoise Mazingue, Pierre Leblond, Alain Martinot.   

Abstract

BACKGROUND: The prognosis of febrile neutropenia (FN) in childhood cancer has been considerably improved by the intensification of treatment, including systematic hospitalization and broad-spectrum antibiotics. As only few children present with a severe bacterial infection (SBI), clinical decision rules have been developed to distinguish those at risk for SBI. The aim of this study was to evaluate the reproducibility of six clinical decision rules proposed in the literature and to compare their performance.
METHODS: This retrospective two-center cohort study included all episodes of chemotherapy-induced FN in children admitted between January 2005 and December 2006. Each rule was applied to our patients. Their sensitivity (Se) and specificity (Sp) were calculated and compared with the authors' results, to assess reproducibility. The most predictive rule was defined in advance as that yielding 100% Se, the highest Sp, and the greatest simplicity for bedside application.
RESULTS: Three hundred seventy-seven episodes of FN in 167 patients were collected; 64 episodes were associated with SBI, including 36 with bacteremia. Four of the six rules were reproducible, but none were able to be validated. The most predictive rule for bacteremia had 96% Se (95% confidence interval (CI): 79-99%) and 25% Sp (95% CI: 19-33%), and the most predictive rule for SBI had 95% Se (95% CI: 87-98%), but no power of discrimination (Sp = 5%, 95% CI: 3-8%).
CONCLUSION: This study emphasizes the difficulty in identifying standardized decision rules in the management of a condition with numerous clinical variables like FN. Copyright 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20806364     DOI: 10.1002/pbc.22586

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  8 in total

1.  Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancer.

Authors:  Adam J Esbenshade; M Cecilia Di Pentima; Zhiguo Zhao; Ayumi Shintani; Jennifer C Esbenshade; Monique E Simpson; Kathleen C Montgomery; Robert B Lindell; Haerin Lee; Ato Wallace; Kelly L Garcia; Karel G M Moons; Debra L Friedman
Journal:  Pediatr Blood Cancer       Date:  2014-10-18       Impact factor: 3.167

Review 2.  Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropenia.

Authors:  Robert S Phillips; Thomas Lehrnbecher; Sarah Alexander; Lillian Sung
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

3.  Predicting Infectious ComplicatioNs in Children with Cancer: an external validation study.

Authors:  Gabrielle M Haeusler; Karin A Thursky; Francoise Mechinaud; Franz E Babl; Richard De Abreu Lourenco; Monica A Slavin; Robert Phillips
Journal:  Br J Cancer       Date:  2017-06-13       Impact factor: 7.640

4.  Pediatric patients at risk for fever in chemotherapy-induced neutropenia in Bern, Switzerland, 1993-2012.

Authors:  Annina N von Allmen; Maxime G Zermatten; Kurt Leibundgut; Philipp Agyeman; Roland A Ammann
Journal:  Sci Data       Date:  2018-03-13       Impact factor: 6.444

5.  Use of biomarkers in the management of febrile neutropenia episodes in children with cancer.

Authors:  Benigna Maria de Oliveira
Journal:  Rev Bras Hematol Hemoter       Date:  2015-12-30

6.  Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.

Authors:  Hilde T van der Galiën; Erik A H Loeffen; Karin G E Miedema; Wim J E Tissing
Journal:  Support Care Cancer       Date:  2018-05-19       Impact factor: 3.603

7.  Episodes of fever in neutropenia in pediatric patients with cancer in Bern, Switzerland, 1993-2012.

Authors:  Maxime G Zermatten; Christa Koenig; Annina von Allmen; Philipp Agyeman; Roland A Ammann
Journal:  Sci Data       Date:  2019-01-15       Impact factor: 6.444

8.  Pro-inflammatory cytokine ratios determine the clinical course of febrile neutropenia in children receiving chemotherapy.

Authors:  Mira Siegmund; Julia Pagel; Tasja Scholz; Jan Rupp; Christoph Härtel; Melchior Lauten
Journal:  Mol Cell Pediatr       Date:  2020-06-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.